A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...
Germany: Researchers have found in a new study that a combined PET/MRI imaging approach with MRI scoring may safely reduce ...
PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the Journal of Nuclear Medicine. By applying the ...
Hypoxia, or insufficient oxygen supply, plays a critical role in solid tumor growth and treatment resistance. The tumor microenvironment influences both the aggressiveness of a tumor and its ability ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...
Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer. PSMA ...
Current PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consistent signals from both PET and MRI. In healthy kidneys, the center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results